Evidence map›Paper›PMID 39924233›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Bilateral Middle Cerebellar Peduncle Sign in a Patient with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy and Coronavirus Disease 2019.

Akihiko Mitsutake, Yuto Sakai, Yoko Tsuboyama, Yusuke Baba, Akira Arakawa, Yuko Saito, Manabu Tsumoto, Shigeru Ikeda, Nobue K Iwata

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akihiko MitsutakeDepartment of Neurology, International University of Health and Welfare Mita Hospital, Japan.
Yuto SakaiDepartment of Neurology, International University of Health and Welfare Mita Hospital, Japan.
Yoko TsuboyamaDepartment of Neurology, International University of Health and Welfare Mita Hospital, Japan.
Yusuke BabaDepartment of Neurology, International University of Health and Welfare Mita Hospital, Japan.
Akira ArakawaDepartment of Neurology and Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Japan.
Yuko SaitoDepartment of Neurology and Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Japan.
Manabu TsumotoDepartment of Neurosurgery, JCHO Tokyo Takanawa Hospital, Japan.
Shigeru IkedaDepartment of Neurology, JCHO Tokyo Takanawa Hospital, Japan.
Nobue K IwataDepartment of Neurology, International University of Health and Welfare Mita Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 59-year-old man without risk factors for atherosclerosis was diagnosed with coronavirus disease 2019 (COVID-19). Four days later, he developed dysarthria and gait disturbance. Neurological examination revealed slurred speech, ataxia, and mild cognitive decline. Brain magnetic resonance imaging revealed multiple infarcts in the bilateral middle cerebellar peduncles and leukoencephalopathy, indicating the diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Genetic testing confirmed a pathogenic NOTCH3 variant (c.505C>T, p.Arg169Cys) (NM_000435.3). A skin biopsy supported the diagnosis. He was treated with cilostazol and after three months of rehabilitation, he regained an independent walking ability. COVID-19 increases the risk of ischemic stroke in CADASIL patients, with bilateral middle cerebellar peduncle infarctions being notable in the present case.

Indexed as

CADASILCerebellumCOVID-19CilostazolHumansMagnetic Resonance ImagingMaleMiddle AgedReceptor, Notch3SARS-CoV-2CilostazolNOTCH3 protein, humanReceptor, Notch3CADASILcerebral infarctionCOVID-19middle cerebellar peduncle

Identifiers

PMID39924233
PMCPMC12097812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.